Subgen AI AB (publ) (OM: SUBGEN)
Salud · Biotecnología · SE
0,03 Skr
-4,32 % hoy · -100,0 % 1 año
Subgen AI AB (publ) (OM: SUBGEN) opera en la industria de biotecnología dentro del sector salud. Su valor en bolsa es de 5,93 M $ y tiene 251 empleados.
En los últimos doce meses la acción ha bajado un 100,0 % y ha cotizado entre 0,03 y 19,60 mil.
Tweenvest puntúa a Subgen AI AB (publ) en cuatro factores: calidad 73/100, valor 66/100. Su punto más fuerte es calidad.
Evolución de la cotización de SUBGEN
Cifras clave
- Capitalización
- 5,93 M $
- Ingresos (últ. 12 m)
- 22,30 M $
- PER
- -0,36
- BPA
- -0,01
- Rent. por dividendo
- —
- Beta (5 años)
- —
- Máximo 52 semanas
- 19.600,00 Skr
- Mínimo 52 semanas
- 0,03 Skr
- Volumen medio (3 m)
- —
- Acciones en circulación
- 2,24 mil M
- Empleados
- 251
- Próximos resultados
- —
Sobre Subgen AI AB (publ)
Subgen AI AB develops artificial intelligence-based models and applications to control data for government and businesses. The company engages in the provision of information society services aimed at delivering financial and related knowledge tools to facilitate third-party access to financial literacy and instruments that enable them to interpret such information through e-learning; the acquisition, ownership, management and administration of securities; and the acquisition, ownership, marketing, leasing and operation of rural or urban properties. It also provides financial intermediation services; computer programming activities, structure and content design, writes computer code for systems, computer software, databases and web pages; and customizes computer programs, including configuration and modification of legacy programs. In addition, the company offers marketing and after-sales services of diagnostic imaging machinery and human resources services, as well as development of state-of-the-art artificial intelligence (Al) systems. Further, it provides Serenity Star, AI4D core, and Substrate Cloud. The company is based in London, United Kingdom. Subgen AI AB operates as a subsidiary of Substrate Artificial Inteligence, S.A.
- ISIN
- SE0026820854
- Cotiza desde
- 10 dic 2025
- Bolsa
- OMX Nordic Exchange Stockholm
- Divisa
- SEK
Otras empresas de biotecnología
| Empresa | Capitalización | Precio | Día |
|---|---|---|---|
| Oncotelic Therapeutics, Inc.OTCPK: OTLC | 6,04 M $ | 0,01 $ | +1,54 % |
| OptiBiotix Health PlcAIM: OPTI | 5,99 M $ | 0,04 £ | -3,30 % |
| COSCIENS Biopharma Inc.TSX: CSCI | 5,98 M $ | 8,60 CA$ | +7,23 % |
| General Biologicals CorporationTPEX: 4117 | 5,94 M $ | 7,48 NT$ | -9,00 % |
| Aprea Therapeutics, Inc.NasdaqCM: APRE | 5,91 M $ | 0,42 $ | -5,41 % |
| Lantern Pharma Inc.NasdaqCM: LTRN | 5,89 M $ | 0,46 $ | -4,24 % |
| Rakovina Therapeutics Inc.TSXV: RKV | 5,79 M $ | 0,19 CA$ | +2,78 % |
| OLIPASS CorporationKOSDAQ: A244460 | 5,72 M $ | 1651,00 ₩ | -13,92 % |